Patients with active SLE show an overall downregulated expression level of H3 and H4 acetylation in CD4+ T cells in vivo, which leads to an increased expression of autoimmune-related genes and an elevated risk of developing autoimmune diseases. This evidence concerns the gene CD4 and systemic lupus erythematosus.